Independent comparison · sources dated

Wellorithm vs Enhance.MD: compare first-month offers with recurring care costs

Compare Wellorithm and Enhance.MD by first-charge and recurring-price evidence, included care, product status, payment language, service area, labs, shipping, and unresolved renewal terms.

Affiliate disclosure: We may earn a commission if you sign up through links below — this doesn't affect our rankings.

Wellorithm and Enhance.MD should be compared as two billing timelines, not as $147 versus $112. Wellorithm's checked page advertises compounded semaglutide starting at $147 and compounded tirzepatide starting at $249, with promotional language describing a first-month discount. The accepted source record does not establish one later-month amount for every product, route, dose, or selection. Enhance.MD makes one transition more visible: its main compounded semaglutide card states $112 for the first month and $212 per month, while its tirzepatide card presents a first-month figure and a higher recurring figure. That added time label is useful, but it still does not freeze future terms or establish the checkout total for every applicant. The practical comparison is first charge, recurring charge, product, dose policy, refill interval, minimum term, and amount at risk before cancellation.

The services surrounding those figures have different disclosure shapes. Wellorithm describes an online evaluation reviewed by licensed professionals, a prescription if approved, direct-to-door shipping, 24/7 access to support, no-insurance-required language, HSA/FSA marketing, and availability in 49 states excluding Louisiana. Its page also markets free shipping and an everything-included structure, yet the frozen evidence does not provide a dispatch or delivery window or a complete later-month schedule. Enhance.MD describes medical intake, laboratory work, an online provider consultation, medication delivery, ongoing provider care, and periodic metabolic lab testing. Its checked program cards identify four weeks of medication and labs every six months for the principal GLP-1 offers. The page also says there is no commitment until consultation and describes a refund when the provider finds a person ineligible during onboarding. Those statements must be read with the current checkout, pharmacy-processing status, shipment state, renewal, and refund terms.

HealthRX and AgelessRx appear only as benchmark context. Their checked pages provide different contract-length, shipping, fulfillment, cancellation, and price disclosures; those figures are not quotes for Wellorithm or Enhance.MD. The direct decision remains Wellorithm versus Enhance.MD: compare the selected product, first charge, recurring charge, medication quantity, laboratory line, clinician support, shipping cadence, cancellation method, and state eligibility. Provider HSA/FSA language does not determine tax eligibility, reimbursement, or a plan administrator's decision. Compounded drugs are not FDA-approved, and FDA does not review them for safety, effectiveness, or quality before marketing. A licensed clinician decides whether to prescribe. No program is a medical winner, and all affiliate routes remain inert.

Fictional adults calmly comparing health-program options at a sunlit kitchen table; generated brand imagery, not real patients

Quick answer · Wellorithm

Decision split: Wellorithm for broader commercial disclosure; Enhance.MD for recurring-price visibility

Wellorithm has the higher frozen evidence score and a lower stated semaglutide starting point, while Enhance.MD more clearly labels a first-month-to-recurring transition and periodic labs. Neither pattern guarantees total cost, approval, delivery timing, or medical fit.1

6.2/10

Choose by intent

Best for what matters to you

Jump to the scored card, verify the cited terms, or use the private matching path. A commercial fit is not a treatment recommendation.

At-a-glance comparison

Compare the same evidence fields

Sort by the weighted score or published starting price. Every score remains tied to the five criteria below.

LogoProviderStarting priceMedications offeredInsuranceAverage waitClinic Scout scorePublic review signalOffer / promoNext steps
HealthRXaffiliate relationship · commission may applyAdvertised from $133/month; the checked page also references $99/month on a 12-month plan5Compounded semaglutide and tirzepatide; compounded drugs are not FDA-approved; clinician approval required5No insurance needed; HSA/FSA eligible; reimbursement is not guaranteed5Independent physician file review within 24 hours; free overnight shipping stated57.4/10
Current offerNo verified promo codeChecked 2026-07-23
AgelessRxaffiliate relationship · commission may applyAdvertised from $159/month6Compounded options; compounded drugs are not FDA-approved; licensed U.S. clinician review stated6Major cards and HSA/FSA accepted; coverage is not promised6Free discreet shipping stated as 3–5 business days66.9/10
Current offerNo verified promo codeChecked 2026-07-23
Wellorithmaffiliate relationship · commission may applyCompounded semaglutide advertised starting at $147 and compounded tirzepatide starting at $249 with first-month promotional language; later-month and selected-product totals require confirmation1Compounded semaglutide and tirzepatide injection and oral-dissolving options are described; the checked page says FDA has not reviewed the compared medications for safety, quality, or effectiveness1No insurance required; HSA/FSA described; merchant acceptance or marketing is not an expense-eligibility, reimbursement, coverage, or tax guarantee1Free direct-to-door shipping stated; dispatch and delivery timing not stated16.2/10
Current offerNo verified promo codeChecked 2026-07-23
Enhance.MDaffiliate relationship · commission may applyCompounded semaglutide advertised from $112 for the first month and $212/month recurring; selected product, offer, consultation, and current checkout control the actual total2Compounded semaglutide and compounded tirzepatide programs are described; prescription products require an online consultation; compounded medication is not FDA-approved2HSA/FSA use described; insurance coverage not stated; expense eligibility, substantiation, and reimbursement depend on the applicable account rules and administrator2Medication shipped to the door; program and refill cadence are described, but no carrier delivery window is stated25.7/10
Current offerNo verified promo codeChecked 2026-07-23

How we evaluated · why trust this

The counts are visible. Missing evidence stays missing.

We compared 4 providers, checked 6 dated sources, and applied 5 published criteria. Scores use the same weighted rubric in the table and every provider card. Commission is excluded from scoring.

Providers
4
Sources
6
Criteria
5
Review points awarded
0 · no comparable set

Lead generation, not advertising. Free · No commitment · 30 seconds. We do not share contact details unless the person separately requests matching and gives explicit consent.

Read the full scoring method

Source-backed deep cards

Provider-by-provider breakdown

Pros, limitations, subscores, and bottom lines come from the same dated evidence that drives the table—not a second hidden ranking.

#1 · Best for Visible clinician workflow and shipping expectations

HealthRX

7.4/10
Current offerNo verified promo codeChecked 2026-07-23

How HealthRX scored

  • Price transparency90/10090/100
  • Care-process visibility90/10090/100
  • Insurance support70/10070/100
  • Public reviews0/1000/100
  • Shipping transparency95/10095/100

Why it stands out

  • Published price evidence: Advertised from $133/month; the checked page also references $99/month on a 12-month plan5
  • Payment and coverage evidence: No insurance needed; HSA/FSA eligible; reimbursement is not guaranteed5
  • Process evidence: Independent physician file review within 24 hours; free overnight shipping stated5

What to verify

  • Compounded products are not FDA-approved5
  • A 12-month rate is not a month-to-month quote5
  • No comparable independent review dataset was verified5

Bottom line

HealthRX stands out here for visible clinician workflow and shipping expectations, based on dated commercial evidence—not medical outcomes or individual suitability.5

#2 · Best for Clear starting price and stated delivery window

AgelessRx

6.9/10
Current offerNo verified promo codeChecked 2026-07-23

How AgelessRx scored

  • Price transparency85/10085/100
  • Care-process visibility80/10080/100
  • Insurance support70/10070/100
  • Public reviews0/1000/100
  • Shipping transparency85/10085/100

Why it stands out

  • Published price evidence: Advertised from $159/month6
  • Payment and coverage evidence: Major cards and HSA/FSA accepted; coverage is not promised6
  • Process evidence: Free discreet shipping stated as 3–5 business days6

What to verify

  • Compounded products are not FDA-approved6
  • Eligibility and availability vary6
  • No comparable independent review dataset was verified6

Bottom line

AgelessRx stands out here for clear starting price and stated delivery window, based on dated commercial evidence—not medical outcomes or individual suitability.6

#3 · Best for Visible starting prices, support language, and a published service-area boundary

Wellorithm

6.2/10
Current offerNo verified promo codeChecked 2026-07-23

How Wellorithm scored

  • Price transparency85/10085/100
  • Care-process visibility65/10065/100
  • Insurance support65/10065/100
  • Public reviews0/1000/100
  • Shipping transparency70/10070/100

Why it stands out

  • Published price evidence: Compounded semaglutide advertised starting at $147 and compounded tirzepatide starting at $249 with first-month promotional language; later-month and selected-product totals require confirmation1
  • Payment and coverage evidence: No insurance required; HSA/FSA described; merchant acceptance or marketing is not an expense-eligibility, reimbursement, coverage, or tax guarantee1
  • Process evidence: Free direct-to-door shipping stated; dispatch and delivery timing not stated1

What to verify

  • Later-month and dose-dependent totals were not verified in the accepted archived extract1
  • Compounded products are not FDA-approved and are not reviewed by FDA before marketing for safety, effectiveness, or quality1
  • Free direct shipping is stated without a dispatch or delivery window1

Bottom line

Wellorithm stands out here for visible starting prices, support language, and a published service-area boundary, based on dated commercial evidence—not medical outcomes or individual suitability.1

#4 · Best for Explicit first-month-to-recurring price transition with provider-care and periodic-lab disclosures

Enhance.MD

5.7/10
Current offerNo verified promo codeChecked 2026-07-23

How Enhance.MD scored

  • Price transparency80/10080/100
  • Care-process visibility70/10070/100
  • Insurance support40/10040/100
  • Public reviews0/1000/100
  • Shipping transparency60/10060/100

Why it stands out

  • Published price evidence: Compounded semaglutide advertised from $112 for the first month and $212/month recurring; selected product, offer, consultation, and current checkout control the actual total2
  • Payment and coverage evidence: HSA/FSA use described; insurance coverage not stated; expense eligibility, substantiation, and reimbursement depend on the applicable account rules and administrator2
  • Process evidence: Medication shipped to the door; program and refill cadence are described, but no carrier delivery window is stated2

What to verify

  • Total cost, current promotion, commitment, and state eligibility require confirmation2
  • Compounded products are not FDA-approved and are not reviewed by FDA before marketing for safety, effectiveness, or quality2
  • Shipment or refill cadence is not a dispatch-to-delivery estimate2

Bottom line

Enhance.MD stands out here for explicit first-month-to-recurring price transition with provider-care and periodic-lab disclosures, based on dated commercial evidence—not medical outcomes or individual suitability.2

Section winners

If you care most about one factor

These are evidence-category leaders, not medical recommendations.

If you want Visible clinician workflow and shipping expectations

Choose HealthRX

HealthRX stands out here for visible clinician workflow and shipping expectations, based on dated commercial evidence—not medical outcomes or individual suitability.5

Read HealthRX review

If you want Clear starting price and stated delivery window

Choose AgelessRx

AgelessRx stands out here for clear starting price and stated delivery window, based on dated commercial evidence—not medical outcomes or individual suitability.6

Read AgelessRx review

If you want Visible starting prices, support language, and a published service-area boundary

Choose Wellorithm

Wellorithm stands out here for visible starting prices, support language, and a published service-area boundary, based on dated commercial evidence—not medical outcomes or individual suitability.1

Read Wellorithm review

What this page does well

What still needs verification

Frequently asked questions

Is Wellorithm's $147 figure the ongoing monthly total?
It is not enough to establish every later charge. Wellorithm's checked page advertises compounded semaglutide starting at $147 and compounded tirzepatide starting at $249, with first-month promotional language. The archived evidence does not establish one universal month-two amount, dose schedule, renewal total, or cart for every product. Request the selected product's first charge, later charge, cadence, inclusions, and cancellation terms in writing.
What does Enhance.MD publish after the $112 first month?
The checked Enhance.MD page states compounded semaglutide from $112 for the first month and $212 per month thereafter. It also displays a first-month and recurring structure for tirzepatide. Those figures are dated advertisements, not quotes, and the selected product, offer, consultation, state access, and checkout can change the amount. Compare at least the first charge and the recurring charge rather than ranking the providers by introductory price alone.
Which provider is clearer about what the charge includes?
Wellorithm says its program includes support and markets no membership or hidden fees, but the accepted source record still requires later-month and product-specific confirmation. Enhance.MD lists four weeks of medication, ongoing provider care and support, and metabolic lab testing every six months for its main GLP-1 program cards. Neither inclusion list replaces an itemized checkout showing consultation, medication, supplies, labs, shipping, refill cadence, and any taxes or other charges.
How do their care workflows differ?
Wellorithm describes an online evaluation, licensed-professional supervision, prescription after approval, direct delivery, and 24/7 team access. Enhance.MD describes medical intake, lab work, an online provider consultation, home delivery, and ongoing provider care. These are published process descriptions, not proof of approval, clinical quality, a particular response time, or a prescription for any individual.
Can I compare delivery speed from the published pages?
Neither checked source supplies a complete carrier window. Wellorithm states free direct-to-door shipping without a dispatch or delivery estimate. Enhance.MD says medication is shipped to the door and describes refill or shipment cadence, but cadence is not elapsed delivery time. Ask when pharmacy processing starts, who dispenses, when tracking appears, how packaging is handled, and what happens after a delay or temperature problem.
Does HSA/FSA wording settle eligibility or insurance coverage?
No. Wellorithm says no insurance is required and uses HSA/FSA marketing language. Enhance.MD describes HSA/FSA use while insurance coverage is not established in the accepted record. Merchant acceptance, possible qualified-medical-expense treatment, reimbursement, substantiation, and insurance coverage are different questions. Obtain an itemized receipt and let the plan administrator decide; this comparison gives no tax or reimbursement guarantee.
Are the compounded options FDA-approved?
No. The compared pages describe compounded options. Compounded drugs are not FDA-approved, and FDA does not review them for safety, effectiveness, or quality before marketing. Wellorithm's own page says the FDA has not reviewed the medications for safety, quality, or effectiveness; Enhance.MD states its compounded medication is not FDA-approved. Ingredient names, clinical supervision, or direct shipping do not establish equivalence to an approved branded drug.
Why did neither provider receive public-review points?
The public-review criterion remains zero for both because no comparable independent dataset was verified across the pair under the frozen rubric. Provider-hosted testimonials, success stories, ratings, and embedded review widgets are not combined into a manufactured corpus. Zero means no review points were awarded from the accepted evidence, not that the services have no online commentary.
What is the safest commercial comparison method for this pair?
Use two ledgers. In a billing ledger, record product, formulation, first charge, recurring charge, dose policy, minimum term, refill cadence, renewal, cancellation, refund, labs, supplies, consultation, and shipping. In a fulfillment ledger, record prescriber, dispensing pharmacy, state access, approval event, pharmacy-processing event, carrier handoff, tracking, storage instructions, and problem-resolution channel. Preserve screenshots and written terms because offers can change after July 23, 2026.

Source ledger

Dated evidence behind this comparison

Reviewed against cited first-party and primary sources · Sources checked 2026-07-23 · How evidence review works

  1. 1WellorithmChecked 2026-07-23
  2. 2Enhance.MDChecked 2026-07-23
  3. 3FDAChecked 2026-07-23
  4. 4FDA online-pharmacy safety guidanceChecked 2026-07-23
  5. 5HealthRX benchmarkChecked 2026-07-23
  6. 6AgelessRx benchmarkChecked 2026-07-23
Check Wellorithm terms on Wellorithm's official siteGet matched privately